<DOC>
	<DOC>NCT02201862</DOC>
	<brief_summary>This study is being conducted to provide clinically annotated samples to support continued improvements in the Ariosa Test content, methodology, specimen processing and quality control.</brief_summary>
	<brief_title>Non-Invasive Chromosomal Evaluation of Trisomy Study</brief_title>
	<detailed_description />
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<mesh_term>Trisomy</mesh_term>
	<criteria>1. Subject is at least 18 years old and can provide informed consent; 2. Subject has a viable singleton or twin pregnancy; 3. Subject is confirmed to be at least 10 weeks, 0 days gestation at the time of the study blood draw; 4. Subject is planning to undergo CVS and/or amniocentesis for the purpose of genetic analysis of the fetus OR the subject has already undergone CVS and/or amniocentesis and is known to have a fetus with a chromosomal abnormality confirmed by genetic analysis. 1. Subject has known aneuploidy; 2. Subject is pregnant with more than two fetuses or has had sonographic evidence of three or more gestational sacs at any time during pregnancy; 3. Subject has a fetal demise (including natural or elective reduction) identified prior to consent; 4. Subject has history of malignancy treated with chemotherapy and/or major surgery, or bone marrow transplant;</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Aneuploidy</keyword>
	<keyword>Down Syndrome</keyword>
	<keyword>amniocentesis</keyword>
	<keyword>chronic villus sampling</keyword>
	<keyword>Trisomy</keyword>
	<keyword>non-invasive prenatal testing</keyword>
	<keyword>Chromosome disorders</keyword>
</DOC>